Universal Ibogaine Provides Update on Kelburn Recovery Center

2022-08-19T14:40:52-07:00August 19th, 2022|Universal Ibogaine News|

Calgary, AB – August 19, 2022 – Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”) is a life sciences company with a mission to deliver medicalized ibogaine-centered addiction care. Ibogaine is a plant derived medicine used in addiction treatment and has been shown to deliver detoxification from opioids, heroin and other substances, and can provide a several month window free [...]

Nick Karos to Present at H.C. Wainwright 1st Annual Mental Health Conference

2022-06-28T14:29:15-07:00June 28th, 2022|Universal Ibogaine News|

Calgary, AB – TheNewswire - June 24, 2022 – Universal Ibogaine Inc. (TSXV:IBO ) , ( OTC:IBOGF ) and ( FSE:JC4) (“ UI ” or the “ Company ”) a life sciences company with a mission to transform addiction treatment using medicalized ibogaine and a global licensing model is pleased to announce that Nick Karos, CEO will present at the H.C. Wainwright 1 st Annual Mental Health Conference: Neuropsychiatry, Psychedelics and Beyond.  The event is a hybrid online and [...]

Universal Ibogaine Engages Investor Relations Firm Blue Digital Media

2022-06-28T14:15:09-07:00June 28th, 2022|Universal Ibogaine News|

Calgary, AB – TheNewswire - June 13, 2022 – Universal Ibogaine Inc. (TSXV:IBO ) , ( OTC:IBOGF ) and ( FSE:JC4) (“ UI ” or the “ Company ”) a life sciences company with a mission to transform addiction treatment through the use of medicalized ibogaine and a global licensing model advises it has engaged investor communications firm Blue Digital Media & Web Solutions (“ Blue Digital ”) for assistance with expanding awareness of UI’s business activities. Blue Digital [...]

Universal Ibogaine Advises Departure of David Danziger from Board of Directors

2022-06-28T14:07:38-07:00June 28th, 2022|Universal Ibogaine News|

Calgary, AB – TheNewswire - June 10, 2022 – Universal Ibogaine Inc. ( TSXV:IBO ) (“ UI ” or the “ Company ”) a life sciences company with a mission to develop and deliver medicalized ibogaine-centered addiction care, advises that David Danziger has resigned as a member of the UI Board of Directors. UI thanks David for his contributions to the Company during his tenure as a Director [...]

Universal Ibogaine Co-Founder Dr. Alberto Sola to Present at Research to Reality Conference

2022-06-28T14:02:45-07:00June 28th, 2022|Universal Ibogaine News|

CALGARY, AB , May 13, 2022 /PRNewswire/ - Universal Ibogaine Inc. (TSXV: IBO) (OTCQB: IBOGF) (FSE: JC4) (" UI " or the " Company ") a life sciences company with a mission to transform addiction treatment through the use of medicalized ibogaine and a global licensing model is pleased to announce that UI Co-Founder Dr Alberto Sola will present at the May 27 to 29 event: From Research to Reality: Global Summit [...]

Universal Ibogaine Retains Shayne Nyquvest as Capital Markets Advisor

2022-06-28T13:50:27-07:00June 28th, 2022|Universal Ibogaine News|

CALGARY, AB , April 29, 2022 /CNW/ - Universal Ibogaine Inc. (TSXV: IBO) (OTCQB: IBOGF) (FSE: JC4) (" UI " or the " Company ") a life sciences company with a mission to develop and deliver medicalized ibogaine-centered addiction care, advises that it has retained Mr. Shayne Nyquvest in a consulting role as Capital Markets Advisor. Mr. Nyquvest has extensive capital markets experience, with over 40 years involvement in [...]

Universal Ibogaine Advises of Departure of Marilyn Mauritz from Board of Directors

2022-05-12T22:15:06-07:00May 12th, 2022|Universal Ibogaine News|

Calgary, AB – April 21, 2022 – Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”) a life sciences company with a mission to develop and deliver medicalized ibogaine-centered addiction care, advises that Marilyn Loewen Mauritz has resigned as a member of the UI Board of Directors to pursue other opportunities.  The Board of Directors would like to thank Marilyn for [...]

Universal Ibogaine Provides Update on Kelburn Recovery Center Operations

2022-05-12T22:06:50-07:00May 12th, 2022|Universal Ibogaine News|

Calgary, AB – April 7, 2022 – Universal Ibogaine Inc. (TSXV:IBO) (“UI” or the “Company”) a life sciences company with a mission to develop and deliver medicalized ibogaine-centered addiction care, advises that it has temporarily closed the Kelburn Recovery Centre (“Kelburn”) due to an on-site flooding issue.  Kelburn is UI’s addiction treatment site operating near Winnipeg, Manitoba, and which experienced [...]

Universal Ibogaine Announces Frankfurt Stock Exchange Listing

2022-04-05T02:48:33-07:00April 5th, 2022|Universal Ibogaine News|

Calgary, AB – April 5, 2022 – Universal Ibogaine Inc. (TSXV:IBO and OTCQB: IBOGF and FSE: JC4) (“UI” or the “Company”) a life sciences company with a mission to transform the world of addiction treatment through medicalized ibogaine and a state of the art ongoing care program, is pleased to announce that its common shares have been approved for trading [...]

Universal Ibogaine to Participate in the 2022 Virtual Growth Conference

2022-03-24T16:10:26-07:00March 24th, 2022|Universal Ibogaine News|

Presented by Maxim Group LLC and hosted by M-Vest on March 28th – 30th from 9:00 a.m. - 5:00 p.m. EDT Calgary, Canada - March 24, 2022 -- [Universal Ibogaine] [TSXV:IBO and OTCQB:IBOGF], a life sciences company with a mission to transform the world of addiction treatment through medicalized ibogaine and a state of the art ongoing care program, announced [...]

Go to Top